Want to join the conversation?
$ADS 2Q15 Call: Epsilon's revenue and adjusted EBITDA increased 39% and 66%, respectively vs. 2Q14. Card Services revenue increased 27%, resulting adjusted EBITDA growth of 20%, 14th consequetive quarter of double-digit revenue growth. Provision for loan losses grew 61%, primarily due to substantital growth in card receivables.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?